albuterol/fluticasone (TEV-'248)
/ Teva
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
April 11, 2025
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
(clinicaltrials.gov)
- P3 | N=2196 | Recruiting | Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Active, not recruiting ➔ Recruiting
Enrollment open • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
March 31, 2025
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
(clinicaltrials.gov)
- P3 | N=2196 | Active, not recruiting | Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Recruiting ➔ Active, not recruiting
Enrollment closed • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
October 29, 2024
Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old
(clinicaltrials.gov)
- P1 | N=30 | Completed | Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Recruiting ➔ Completed | N=22 ➔ 30
Enrollment change • Trial completion • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
April 24, 2024
Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old
(clinicaltrials.gov)
- P1 | N=22 | Recruiting | Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
March 04, 2024
Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old
(clinicaltrials.gov)
- P1 | N=22 | Not yet recruiting | Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
New P1 trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
September 25, 2023
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
(clinicaltrials.gov)
- P3 | N=2196 | Recruiting | Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
New P3 trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
1 to 6
Of
6
Go to page
1